These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23024007)

  • 1. Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future.
    Rajappan K
    Heart; 2013 Mar; 99(6):361-2. PubMed ID: 23024007
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban in acute coronary syndromes and atrial fibrillation: rivaroxaban shown to reduce cardiovascular deaths in STEMI patients.
    Aalbers J
    Cardiovasc J Afr; 2012 Oct; 23(9):525-6. PubMed ID: 23108522
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissolution of the left atrial appendage thrombus with rivaroxaban therapy.
    Takasugi J; Yamagami H; Okata T; Toyoda K; Nagatsuka K
    Cerebrovasc Dis; 2013; 36(4):322-3. PubMed ID: 24192983
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.
    Paikin JS; Manolakos JJ; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):965-72. PubMed ID: 23030284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
    Contractor T; Levin V; Martinez MW; Marchlinski FE
    Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Society of Cardiology congress 2011.
    Cardiovasc J Afr; 2011; 22(5):287-8, 291-2. PubMed ID: 21983959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rivaroxaban in prevention of stroke in patients with atrial fibrillation].
    Simonyi G; Medvegy M
    Ideggyogy Sz; 2012 Nov; 65(11-12):365-8. PubMed ID: 23289170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raft of rivaroxaban good news from the USA, implications for South African clinical practice.
    Cardiovasc J Afr; 2011; 22(6):345-6. PubMed ID: 22159327
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention and therapy of thromboembolism: rivaroxaban - better outcome - risk profile as standard therapy].
    MMW Fortschr Med; 2013 Sep; 155(15):56-7. PubMed ID: 24224377
    [No Abstract]   [Full Text] [Related]  

  • 13. Rivaroxaban equals warfarin treatment in atrial fibrillation patients at high risk of stroke.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(6):342-3. PubMed ID: 21135986
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
    Morales-Vidal S; Schneck MJ; Flaster M; Biller J
    Expert Rev Neurother; 2012 Feb; 12(2):179-89; quiz 190. PubMed ID: 22288673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy.
    Ann Intern Med; 2013 Jun; 158(12):I-28. PubMed ID: 23778921
    [No Abstract]   [Full Text] [Related]  

  • 16. New alternative to warfarin may help reduce stroke risk in patients with AF.
    Mitka M
    JAMA; 2011 Jan; 305(1):25-6. PubMed ID: 21205957
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of stroke in patients with atrial fibrillation: a role of modern anticoagulants].
    Anisimova AV; Gendlin GE; Borisov SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9 Pt 2):62-9. PubMed ID: 24107898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
    Ahrens I; Lip GY; Peter K
    Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral anticoagulants for atrial fibrillation: Which one to choose?
    Ribowsky JH; Ismael AG
    Adv NPs PAs; 2012 May; 3(5):31-2. PubMed ID: 22670305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.